Kaiser Permanente names Mike Bowers president of Northern California Region
Bowers has served as interim leader since February 2025. Kaiser Permanente has named Mike Bowers as president of Kaiser Foundation Health Plan and Hospitals in Northern...
Category : Clinical Research, Pharma & Healthcare Financing
CaseBioscience Launches Next-Gen Biopreservation Products
Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across cell therapy workflows CaseBioscience® announces the launch of CaseCryo® CTG DMSO ,...
Piramal and Blue-Zone Team Up to Recycle Anaesthesia Gas
Piramal Critical Care, Inc. (PCC), an overseas subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. (Blue-Zone) announced an agreement to collaborate on full lifecycle...
Pulse Biosciences Shares nPulse™ Cardiac Catheter Data
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the...
Pfizer Launches TrumpRx Program to Cut Drug Costs
Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today,...
Oncolytic Virus Trials Accelerate as 100+ Companies Advance Research
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders,...
China Approves Promega MSI Kit as KEYTRUDA® Companion Test
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China....
WuXi Biologics, Vertex Sign License for T-cell Engager
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service...
Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint Vetter, one of the world’s leading pharmaceutical service providers for the production of injectable...
PranaX Closes $17M Oversubscribed Series A Round
PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series A...
Novaliq Gets FDA IND Clearance for NOV05 Uveitis Trial
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food...
Tenpoint Raises $235M to Launch YUVEZZI™ for Presbyopia
U.S. FDA Approves YUVEZZI™ as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking...
Preclinical Data Supports TPC-026 for Chronic Metabolic Disorders
TETRAPHARM, a Copenhagen-based biopharmaceutical company focused on neuroscience, psychiatry, and metabolic disorders, today announced promising preclinical data for TPC-026, a novel investigational compound being developed for...
EU Approves Guerbet Elucirem™ Half-Dose for Children from Birth
Guerbet (FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, is delighted to announce the approval by European Commission of a...
Bayer to Present Phase III OCEANIC-STROKE Results
Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during...